Lijian Hui
- Hepatology top 0.5%
- Liver physiology and pathology 27
- Molecular Biology top 2%
- Pluripotent Stem Cells Research 11
- CRISPR and Genetic Engineering 10
- Melanoma and MAPK Pathways 5
- Cancer Research top 2%
- Cell Biology top 2%
- Aging top 5%
-
- Pancreatic function and diabetes 20
- Organ Transplantation Techniques and Outcomes 10
-
- Cancer-related Molecular Pathways 8
- Cytokine Signaling Pathways and Interactions 7
Lijian Hui
86 papers receiving 6.0k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Hepatology 1.5k
- Molecular Biology 3.7k
- Cancer Research 791
- Cell Biology 567
- Aging 59
Countries citing papers authored by Lijian Hui
This map shows the geographic impact of Lijian Hui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijian Hui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijian Hui more than expected).
Fields of papers citing papers by Lijian Hui
This network shows the impact of papers produced by Lijian Hui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijian Hui. The network helps show where Lijian Hui may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lijian Hui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 17 | |
| 3 | 2023 | 6 | |
| 4 | 2021 | 3 | |
| 5 | 2020 | 76 | |
| 6 | 2019 | 88 | |
| 7 | 2018 | 213 | |
| 8 | 2018 | 16 | |
| 9 | 2018 | 9 | |
| 10 | 2017 | 26 | |
| 11 | 2017 | 59 | |
| 12 | 2017 | 31 | |
| 13 | 2017 | 108 | |
| 14 | 2016 | 3 | |
| 15 | 2016 | 12 | |
| 16 | 2016 | 22 | |
| 17 | 2016 | 55 | |
| 18 | 2015 | 13 | |
| 19 | 2013 | 27 | |
| 20 | 2010 | 215 |
About Lijian Hui
Lijian Hui is a scholar working on Hepatology, Oncology and Molecular Biology, having authored 88 papers that have together received 6.1k indexed citations. Recurring topics across this work include Liver physiology and pathology (27 papers), Pancreatic function and diabetes (20 papers), Pluripotent Stem Cells Research (11 papers), CRISPR and Genetic Engineering (10 papers), Organ Transplantation Techniques and Outcomes (10 papers), Cancer-related Molecular Pathways (8 papers), Cytokine Signaling Pathways and Interactions (7 papers) and Melanoma and MAPK Pathways (5 papers). The work is most often cited by research in Hepatology (1.5k citations), Molecular Biology (3.7k citations) and Cancer Research (791 citations). Lijian Hui has collaborated with scholars based in China, United States and Austria. Frequent co-authors include Erwin F. Wagner, Pengyu Huang, Ewa Stępniak-Konieczna, Yiping Hu, Harald Scheuch, Latifa Bakiri, Dao Xiang, Chang‐Cheng Liu, Jin Cen and Xin Wang. Their work appears in journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.